Skip to main content
SpringerLink
Log in

Is sildenafil effective in secondary pulmonary hypertension due to systemic lupus erythematosus? A case report

  • Letter
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ling-Te Pan T, Thumboo J, Boey M-L (2000) Primary and secondary pulmonary hypertension in systemic lupus erythematosus. Lupus 9:338–342

    Article  PubMed  Google Scholar 

  2. Molina J, Lucero E, Luluaga S (2003) Systemic lupus erythematosus-associated pulmonary hypertension: good outcome following sildenafil therapy. Lupus 12:321–323

    Article  CAS  PubMed  Google Scholar 

  3. Watanebe H, Ohashi K, Takeuchi K (2002) Sildenafil for primary and secondary pulmonary hypertension. Clin Pharmacol Ther 71:398–402

    Article  PubMed  Google Scholar 

  4. Ooiwa H, Miyazawa T, Yaminishi Y (2000) Successful treatment of systemic lupus erythematosus and pulmonary hypertension with intravenous prostaglandin I2 followed by its oral analogue. Intern Med 39:320–323

    CAS  PubMed  Google Scholar 

  5. Shelley S (2003) Management of pulmonary hypertension resulting from interstitial lung disease. Curr Opin Pulm Med 9:426–430

    Article  PubMed  Google Scholar 

  6. Pearl JM, Wellman SA, McNamara JL (1999) Bosentan prevents hypoxia-reoxygenation-induced pulmonary hypertension and improves pulmonary function. Ann Thorac Surg 68:1714–1721

    Article  CAS  PubMed  Google Scholar 

  7. Wilkens H, Guth A, König J (2001) Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension. Circulation 104:1218–1222

    CAS  PubMed  Google Scholar 

  8. Abrams D, Schulze-Neick I, Magee AG (2000) Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension. Heart 84:E4

    Article  CAS  PubMed  Google Scholar 

  9. Littera R, La Nasa G, Derchi G (2002) Long-term treatment with oral sildenafil in a thalassemic patient with pulmonary hypertension. Blood 100:1516–1517

    Article  CAS  PubMed  Google Scholar 

  10. Ghofrani H, Wiedemann R, Rose F (2002) Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial. Lancet 360:895–900

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Chest Medicine, Çukurova University, School of Medicine, Adana, Balcali, 01330, Turkey

    Ismail Hanta & Ali Kocabas

  2. Department of Cardiology, Çukurova University, School of Medicine, Adana, Turkey

    Mesut Demir & Onur Akpinar

  3. Department of Rheumatology, Çukurova University, School of Medicine, Adana, Turkey

    Suleyman Ozbek

Authors
  1. Ismail Hanta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mesut Demir
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Onur Akpinar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ali Kocabas
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Suleyman Ozbek
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ismail Hanta.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hanta, I., Demir, M., Akpinar, O. et al. Is sildenafil effective in secondary pulmonary hypertension due to systemic lupus erythematosus? A case report. Clin Rheumatol 24, 671–672 (2005). https://doi.org/10.1007/s10067-005-1090-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-005-1090-0

Keywords

Search

Navigation